Sommeijer, D.W. et al. 2014. The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17. Acta Oncologica. 53, 7 (Jul. 2014), 877–884. DOI:https://doi.org/10.3109/0284186X.2013.879202.